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INTRODUCTION
Protective immunity against pre-erythrocytic stages induced by live radiation-attenuated sporozoites (RAS) is mediated, at least in part, by antigen-specific CD8+ T cells (Weiss et al. 1988; Rodrigues et al. 1997; Chakravarty et al. 2007; Schmidt et al. 2008; Bayarsaikhan et al. 2015; Hollingdale and Sedegah 2017) , although antibodies likely contribute to protection (Rodrigues, Nussenzweig and Zavala 1993) . Depletion of CD8+ T cells abolishes sterile immunity in rodents (Schofield et al. 1987; Doolan and Hoffman 2000; Schmidt et al. 2010 ) and non-human primates (Weiss and Jiang 2012) , transfer of parasite-specific CD8+ T cells protects mice against sporozoites (Romero et al. 1989; Weiss et al. 1992 ) and CD8+ T cells do not confer protection in MHC class I-deficient mice (White, Snyder and Krzych 1996) . While some of the broad aspects of the host immune response to RAS have been identified, many of the specific interactions between effector cells and the infected hepatocyte remain to be determined (Cockburn, Tse and Zavala 2014) . High numbers of parasite-specific CD8+ T cells are required to completely protect mice Van Braeckel-Budimir and Harty 2014) , although levels of CD8+ T cells in humans may be lower (Ewer et al. 2013 ). However, RAS immunization studies in mice have suggested that liver-resident CD8+ T cells are a major mediator of protection (Epstein et al. 2011; Nganou-Makamdop et al. 2012; Tse et al. 2013 ). More direct evidence was provided when a monoclonal antibody to CXCR3, expressed by all liver-resident memory CD8+ T cells, was injected into RAS-immunized mice, and protection was significantly reduced (Fernandez-Ruiz et al. 2016) .
Of major interest is whether direct contact between antigenspecific CD8+ T cells and infected hepatocytes is required. Adoptive transfer of Plasmodium yoelii CSP 280-288 CD8+ T cell line significantly reduced parasite burden in the liver of transgenic mice only expressing MHC K d on hepatocytes, suggesting that MHC class I molecules on hepatocytes are major mediators of antigen-specific protective CD8+ T cells (Huang et al. 2015) .
Recent in vivo studies have suggested that P. yoelii RAS-induced CD8+ CSP-specific T cells clustered around P. yoelii-infected hepatocytes Bayarsaikhan et al. 2015) and recruited non-specific and specific activated CD8+ T cells (Bayarsaikhan et al. 2015; Frevert and Krzych 2015) . This clustering was antigen-specific as in vivo activated transgenic CD8+ T cells specific for the P. yoelii CSP 280-288 (SYVPSAEQI) epitope similarly clustered around infected hepatocytes and recruited circulating memory CD8+ T cells to that site . Direct observation of T cell-hepatocyte interaction was not reported, but other direct imaging studies using adoptive transfer of CD8+ T cells specific for the Py CSP 280-288 epitope suggested that these T cells remained in the hepatic microvasculature (Butler, Schmidt and Harty 2010; Schmidt, Butler and Harty 2011) and none of the CD8+ T cells appeared to make direct contact with infected hepatocytes (Cabrera et al. 2013) . However, the fenestration of liver sinusoidal epithelium has been suggested to allow contact between hepatocytes and sinusoidal T cells that patrol for surveillance of hepatocyte infection (Guidotti et al. 2015) . This also suggested that CD8+ T cells may eliminate infected hepatocytes by release of soluble mediators such as IFN-γ (Mellouk et al. 1987; Schofield et al. 1987; Frevert et al. 2014; Miller et al. 2014; Frevert and Krzych 2015) . IFN-γ is thought to induce inducible nitric oxide synthase (iNOS)-mediated production in infected hepatocytes (Nussler et al. 1993; Seguin et al. 1994; Klotz et al. 1995) , but the exact role of IFN-γ is not fully elucidated (Doolan and Hoffman 2000; Overstreet et al. 2008; Butler, Schmidt and Harty 2010; Frevert and Krzych 2015) . However, knockout studies suggest that mediators other than IFN-γ such as FasL and perforin may also be involved as protection (Morrot and Zavala 2004; Kimura et al. 2013) .
A major question is how CD8+ T cells are induced to release IFN-γ and whether this required direct contact between CD8+ T cells and infected hepatocytes, or whether other antigenpresenting cells within the liver sinusoid may interact with CD8+ T cells, although bystander effects were not found at least in mice (Cockburn, Tse and Zavala 2014) .
In vitro cultures of Plasmodium liver stage parasites have afforded opportunities to study these interactions, and early studies demonstrated that RAS induced spleen cell CD8+ T cells in mice that eliminated cultured hepatocytes infected with liver stages that was antigenically and genetically restricted (Hoffman et al. 1989 (Hoffman et al. , 1990 Butler, Schmidt and Harty 2010) , although these studies did not directly examine spleen cellhepatocyte interactions. When BALB/c (H2 d ) mice were immunized with plasmid DNA encoding the P. yoelii circumsporozoite protein (PyCSP) followed by boosting with recombinant vaccinia containing the PyCSP gene in BALB/c (H2 d ) mice (Sedegah et al. 1998 (Sedegah et al. , 2002 , protection was primarily mediated by CD8+ T-cells, interferon-gamma (IFN-γ ) and iNOS (Doolan and Hoffman 2000) that was blocked by L-arginine (NGMML-arginine) supporting the role of iNOS (Sanchez et al. 1994) . Using an in vitro hepatocyte culture assay (Sacci 2002) , in vitro restimulated spleen cells from immunized mice significantly inhibited liver stage development when co-cultured with P. yoelii-infected hepatocytes (Sedegah et al. 2000) . The goal of this study was to further characterize the interactions between immune effector cells and infected hepatocytes. Here, this work was now extended to demonstrate that spleen cells, from prime-boost immunized mice that had not been restimulated in vitro, could also significantly inhibit liver stage parasite development. This suggested a very high precursor frequency of CD8+ T cells directed to P. yoelii CSP that was confirmed by ELISpot IFN-γ assays, consistent with the requirement for a high threshold frequency for sterile immunity (Schmidt et al. 2008) . Furthermore, inhibition was dependent on close physical contact between effector and target, and was eliminated when a semipermeable membrane separated the effector and target. Inhibition of liver stage parasite development was also significantly reduced by the addition of monoclonal antibodies directed against intercellular adhesion molecule-1 (ICAM-1) and IFN-γ . Inhibitors of iNOS, caspase activation and NF-κB activation also reduced the capacity of spleen cells from immunized mice to inhibit parasite development.
MATERIALS AND METHODS

Animals
Female BALB/c (H2 d ) mice were used for immunizations and as a source of hepatocytes. C57Bl/6 (H2 b ) mice were used as a source of hepatocytes for MHC-mismatched control assays.
Parasites
The 17XNL clone 1.1(non-lethal) strain of Plasmodium yoelii and the NK65 strain of P. berghei were used for all the in vitro infections. Parasites were isolated from infected salivary glands using a modification of the Ozaki technique for the rapid isolation of sporozoites (Ellis et al. 1983; Sacci 2002) .
Mouse immunization
Mice were primed and boosted at 6-week intervals with 100 μg of the P. yoelii plasmid DNA construct 1020PyCSP by intramuscular injection into the tibialis anterior muscle (D-D regimen). In another group, the plasmid immunization included the murine GM-CSF plasmid (pGMCSF) as an adjuvant (Weiss et al. 1988 ) and these mice were also boosted 6 weeks later by i.p. injection with a recombinant vaccinia virus construct (rvPyCSP) containing the P. yoelii circumsporozoite gene (DG-V regimen). Negative control mice were primed with empty plasmid plus pGMCSF followed by boosting with rvPyCSP (CG-V regimen) that did not induce protection. The construction of the P. yoelii plasmid DNA and recombinant virus has been described previously (Sedegah et al. 1998) . Spleens were harvested and processed at 14 days after the last immunization (Sedegah et al. 2000) .
Hepatocyte cell culture
Mouse hepatocytes were obtained by in situ collagenase perfusion of mouse liver as previously described (Franke et al. 2000; Sacci 2002 ). Briefly, livers were sequentially perfused in situ with Hank's Balanced Salt Solution containing 0.025% collagenase type 2 (Worthington, Lakewood, NJ, USA). The resulting cell suspension was then centrifuged over Percoll medium (1.06 mg/mL) (Kreamer et al. 1986 ) to remove dead cells. The hepatocytes were seeded onto 4 or 8-well lab-tek chamber slides (Nunc, Thermo Fisher, Waltham, MA) in Minimum Essential Medium with Earle's balanced salts supplemented with 0.2% BSA (fraction 5), 10% fetal calf serum, 2% penicillin-streptomycin solution, insulin, 1% L-glutamine solution (×100) and 1% nonessential amino-acids solution (×100) at a concentration of 1 or 2 × 10 5 cells/well. The slides were incubated overnight at 37
• C in a 5% CO 2 /95% air environment. The media was changed the following day and fresh media containing dexamethasone (7 × 10 −5 M) was added to the cultures.
In vitro culture of Plasmodium yoelii liver stages in culture mouse hepatocytes
Hepatocyte cultures were incubated with P. yoelii or P. berghei sporozoites for 3 h. The cultures were then washed with complete medium and placed in a C0 2 incubator for 24 h prior to the addition of spleen effector cells. Effector cells were added to the cultures 24 h after parasite infection and the chamber slides were then incubated for an additional 24 h and then fixed for 10 min in ice-cold absolute methanol and stained with NYLS3 (a monoclonal antibody against mature Py liver stages for P. yoelii-infected cultures) or Pb 3.28 (a monoclonal antibody against Pb CSP for P. berghei-infected cultures), followed by a FITC-labeled goat anti-mouse IgG. The stained slides were mounted with Vectashield (Vector Labs, Burlingame, CA) and then viewed and counted using an epifluorescence microscope.
Spleen cells
Spleen cells from immunized and control-immunized mice were processed and cultured as described (Sedegah et al. 2000) . In some experiments, spleen cells were restimulated with the H2 
Co-culture of splenocytes and Plasmodium yoelii-infected hepatocytes
Hepatocyte cultures, in 4-well or 8-well chamber slides, were used in a co-culture system to assess the capacity of immune spleen cells to inhibit parasite development. In some studies, 4-well lab-tek chamber slides with semipermeable (pore size 0.2 μm) polycarbonate membrane inserts (Nunc, Thermo Fisher, Waltham, MA) were used to determine if contact between spleen cells and infected hepatocytes was required for inhibition of liver stage parasite development. Inserts were Nunc Anopore membrane inserts, 10 mm diameter, 0.2 μm (Product number 12-565-285B). Spleen cells were directly added to infected hepatocyte monolayers (Fig. 1A) , were placed in membrane inserts that physically separated them from the hepatocytes (Fig. 1B) or were co-cultured with infected hepatocytes, or P815 cells pulsed with the H-2 d -restricted PyCSP minimal CD8+ T-cell epitope SYVP-SAEQI as previously described (Sedegah et al. 2000) (in order to mimic infected BALB/c (H-2 d ) hepatocytes), in the membrane inserts above a second layer infected hepatocyte monolayers below (Fig. 1C) . The membrane insert prevented cell-to-cell contact but allowed soluble mediators to diffuse into the hepatocyte monolayer on the bottom of the chamber. Spleen cells from control immunized BALB/c mice served as negative control effector wells. All inhibition studies were performed in triplicates using these culture systems.
Identification of factors involved in in vitro spleen cell elimination of liver stages
To investigate the roles of cellular factors in spleen cell killing of infected hepatocytes, the co-culture experiments were modified by depletion of the following factors: Depletion of CD4± and CD8± T cells: Immune spleen cells were depleted of either CD4+ or CD8+ T cells using anti-CD4+ or CD8+ magnetic Dynabeads R according to the manufacturer's directions (Thermo Fisher, Waltham, MA) (Sedegah et al. 2011) prior to their addition to infected cultures.
IFN-γ activity produced by CD8± T cells:
Antibodies that block the activity of IFN-γ (XMG1.2) were added to the infected cultures prior to the addition of splenocytes.
Lymphocyte adhesion molecules: The role of ICAM-1 in mediating adhesion to hepatocytes was determined by adding an anti-ICAM-1 antibody (R&D systems, Minneopolis, MN) to cultures containing infected hepatocytes prior to the addition of immune splenocytes.
Inhibition of iNOS:
The inhibitor 1400W (Calbiochem, San Diego, CA) was added to cultures with splenocytes.
Role for NFκB: The irreversible inhibitor of NFκB phosphorylation (BAY 11-7082; (E)-3-[(4-methylphenyl)-sulfonyl]-2-propenenitrile, Calbiochem, San Diego, CA) was added to infected hepatocyte cultures before splenocytes.
Role of the proteosome: Engagement of CD8+ T cells to infected hepatocytes requires parasite peptide to be recognized in the context of class I and inhibition of proteasome function interferes with TAP-mediated processing of malaria antigens with class I molecules (Pichugin et al. 2016) . To assess the role of the proteasome, lactacystin (Calbiochem, San Diego, CA) was used to inhibit proteasome function.
Role of caspase: The role of caspase activation was also assessed by using an irreversible pan caspase inhibitor (z-vad-fmk, Calbiochem, San Diego, CA).
At the concentrations used, none of the inhibitors had a direct toxic effect upon hepatocytes or interfered with parasite development when added alone to cultures. The compounds were tested in infected cultures and the parasite development was assessed as described above in the inhibition of liver stage development assay (ILSDA). Proteosome and NF-κB inhibitors were added to the infected hepatocytes and the media subsequently changed prior to the addition of effector spleen cells so that the inhibitors would not affect the spleen cells.
Ex vivo ELISpot assay
The number of P. yoelii antigen-specific IFNγ -producing cells was determined in freshly isolated spleen cells using modified methods previously described (Sedegah et al. 2000) . Briefly, spleen cells were incubated for 36 h at 37
• C and 5% CO 2 with irradiated P815 target cells pulsed with the H2 d P. yoelii CD8+ T-cell epitope. 96-well nitrocellulose plates (Millipore Corp. Bedford, MA, USA) were coated with 100 μl of PBS containing 5 μg/mL of purified rat anti-mouse IFNγ mAb (BD Pharmingen, San Diego, CA, USA). After overnight incubation at room temperature, the wells were repeatedly washed with culture medium and incubated for 1 h with 100 μl of culture medium. The starting concentration for the freshly isolated spleen cells was 16-36 × 10 6 /mL, and 2-fold dilutions in triplicates were assayed. Target cells were used at 2 to 4 × 10 5 cells/mL and dispensed at 100 μl per well. Peptides at a concentration of 10 μg/mL were dispensed at 100 μl per well. After incubation at 37 • C and 5% CO 2 for 36 h, the plates were extensively washed with PBS containing 0.05% Tween 20 (PBS/T). The wells were then incubated with 100 μl of a solution of 1 μg/mL of biotinylated antimouse IFNγ -mAb (BD Pharmingen, Sandiego, CA) in PBS/T. After overnight incubation at 4 • C, wells were washed with PBS/T and 100 μl of peroxidase-labeled streptavidin (Kirkegaard and Perry Laboratories, KPL, Gaithersburg, MD) at a dilution of 1/1000 in PBS/T was added to each well. After 1-h incubation at room temperature, wells were washed twice with PBS/T and twice with PBS. The spots were developed by following the manufacturer's instructions provided with the DAB Reagent set (Kirkegaard and Perry Laboratories, KPL, Gaithersburg, MD) and activities were 
Cytokine ELISA
A mouse IFN-γ ELISA kit (Thermo Fisher, Waltham, MA) was used, according to the manufacturer's instructions, to quantify IFN-γ production in the ILSDA cultures. Culture supernatants were harvested just before the cultures were fixed and stored at -80 • C. A standard curve was generated with recombinant mouse interferon, and the values for the test cultures were determined by regression analysis from the standards and recorded as pg/mL.
Statistics
The one-way ANOVA and two-tailed Student t-test were used to determine the significance of variation between test samples. All p values ≤0.05 were considered to be significant.
RESULTS
Stimulation of immune spleen cells with PyCSP CTL peptide increased inhibition of parasite development in hepatocytes
Spleen cells from DNA-DNA (D-D) immunized mice displayed modest inhibitory activity (25%) without in vitro restimulation with the PyCSP CTL peptide that increased after peptide stimulation (58%); however, inhibitory activities of spleen cells from mice immunized with the DNA-vaccinia regimen (DG-V) were higher without restimulation (47%) or with restimulation (73%) than the D-D regimen (Table 1) . Since the DG-V regimen also induced higher protection (Sedegah et al. 2000) , the DG-V regimen was used in all subsequent experiments.
Inhibition was parasite species specific and genetically restricted
Using the co-culture system shown in Fig. 1A Fig. 1 in which some cultures had splenocytes directly added to hepatocyte monolayer (Fig. 1A) , added to culture well insert seperating splenocytes from hepatocytes (Fig. 1B) or splenocytes and P815 cells in culture well insert (Fig. 1C) .
* Statistically significant difference from control (P < 0.005). After showing that the effect was antigen specific and genetically restricted, a series of experiments were undertaken to determine if elimination or inhibition of parasite development in hepatocytes required contact between the effector cells and their targets.
Spleen cell-hepatocyte contact is required for killing malaria parasites within hepatocytes
Co-cultures were then performed using different configurations to allow close contact between targets and effectors or to separate them from each other by a semipermeable membrane (Fig. 1A-C , Table 2 ). Results from the different modifications showed that inhibition was dependent on the spleen and target P. yoelii-infected hepatocytes being in close contact. With no membrane insert (Fig. 1A) , unstimulated spleen cells significantly (P = <0.005) reduced the numbers of hepatocyte P. yoelii parasites by 51% compared to negative control CG-V spleen cells (Table 2) . With the membrane insert (Fig. 1B) , this inhibition was totally abrogated (Table 2) , and inhibition was almost totally restored (40%, P = <0.005) by adding p815 cells to the immune spleen cells (Fig. 1C, Table 2 ). P815 cells that were not pulsed with the PyCSP peptide did not have any such effect (Table 2) . IFN-γ was detected when spleen cells and hepatocytes were in close contact or after adding p815 cells but not in the presence of the membrane insert (Table 2) . Next, these experiments were repeated using PyCSP peptidestimulated DG-V spleen cells (Table 3) . Without the membrane insert (Fig. 1A) , restimulated spleen cells significantly (P = <0.001) reduced the numbers of hepatocyte P. yoelii parasites by 67% compared to negative control CG-V spleen cells (Table 3) . With the membrane insert, there was no reduction (Table 3) ; however, inhibition was partially restored (25%, P = <0.01) by adding P. yoelii-infected hepatocytes (Fig. 1C) to the immune spleen cells (Fig. 1C, Table 3 ). The importance of IFN-γ was shown when an anti-IFN-γ antibody was added to the DGV spleen cells cultured with P yoelii-infected hepatocytes; spleen cells had no inhibitory effect on P. yoelii development in the presence of the anti-IFN-γ antibody (Table 3 ).
These results demonstrate that IFN-γ was released from immune spleen cells when co-cultured with p815 cells or P. yoeliiinfected hepatocytes that could diffuse through the insert to the hepatocyte parasite monolayer below and inhibit development of liver stage parasites.
Role of CD4+ and CD8+ T cells
Inhibition assays were also undertaken in which the spleen cell populations were depleted of either CD4+ or CD8+ T cells. Those studies clearly identified CD8+ T cells as the effectors responsible for inhibition of liver stage development (Table 4) , as their depletion abrogated parasite killing. Conversely, CD4+ depletion did not change the ability of the ex vivo spleen cell preparations to inhibit parasite development. In all of these studies, the spleen cells were not restimulated with the P. yoelii CS CTL peptide.
Role of other mediators
Additional studies were performed to identify other possible mediators that may be involved in the DG-V spleen cell Caspase-1 inhibitor (z-vad-fmk) 85 ± 6 1 9 0 . 0 5 † Anti-ICAM-1 antibody 103 ± 7 1 1 0 . 0 5 † * Statistically significant difference from negative control (P < 0.05). † Statistically significant difference from positive control (P < 0.05). ‡ Statistically significant difference from positive control (P < 0.005).
inhibition of P. yoelii development parasite development within hepatocyte monolayers without the membrane insert (Table 5). iNOS inhibitor (1400W), an inactivator of NFκB (BAY 11-7082), proteosome inhibitor (lactacystin) and caspase-1 inhibitor (z-vad-fmk) reduced the inhibitory activity of the spleen cells by up to 100% suggesting the involvement of these factors in spleen cell elimination of the intracellular parasites. Plasmodium-infected cultures also included an anti-ICAM-1 antibody that also significantly reduced parasite killing by spleen cells (Table 5) .
DISCUSSION
Spleen cells from BALB/c mice immunized with a DNA/vaccinia virus vaccine encoding PyCSP eliminated Plasmodium yoelii liver stage parasite in in vitro cultured mouse hepatocytes, and were dependent on CD8+ T cells and IFN-γ . There are three main interpretations of these results: first, that direct contact between antigen-specific CD8+ T cells and P. yoelii-infected mouse hepatocytes was required for CD8+ T cell elimination of liver stage parasites, at least in vitro; second, that in the absence of direct contact with P. yoelii-infected mouse hepatocytes, stimulation of antigen-specific CD8+ T cells by a class I P. yoelii CSP epitope presented by peptide pulsed p815 cells in the context of MHC class I molecules induced release of IFN-γ that mediated elimination of liver stages; and third, presentation of the P. yoelii epitope by P. yoelii-infected hepatocytes to CD8+ T cells also induced release of IFN-γ .
These outcomes can also be interpreted in the context of liver sinusoids that are lined by endothelial cells separated from hepatocytes by the space of Disse. Recently, liver resident T cells have been shown to patrol sinusoids for the presence of malaria liver stage-infected hepatocytes, when they halt and appear to interact with hepatocytes via protrusions from the CD8+ T cells through the fenestrae towards the hepatocytes (Fernandez-Ruiz et al. 2016) . Therefore, the data presented here are consistent with these observations and together suggest that direct contact between CD8+ T cells and malaria-infected haptocytes is required for elimination of the parasite.
The role of CD8+ T cells expressing perforin in protection has also been suggested (Doolan and Hoffman 2000; Trimnell et al. 2009; Butler, Schmidt and Harty 2010; Seder et al. 2013) and TEHLI could mediate Fas/FasL cytotoxicity but may be incapable of mediating perforin, which require larger areas of lymphocyte-hepatocyte interactions and would be dependent on CD8+ T-cell passage through the endothelium into the space of Disse (Frevert and Krzych 2015) . Since CD8+ T cells do not appear to passage through endothelium (Crispe 2011) , alternative pathways involving other sinusoidal cells such as Kupffer cells have been suggested (Doolan and Hoffman 2000; Butler, Schmidt and Harty 2010; Frevert and Krzych 2015) . Recently, intrahepatic surveillance of the liver by CD8+ T cells has been visualized and suggested that CD8+ T cells recognized antigens expressed on hepatocytes while in the blood sinusoid (Guidotti et al. 2015) . Confocal 3D imaging revealed small CD8+ T-cell protrusions penetrating the sinusoidal wall probably through the fenestrae and gaining contact with hepatocytes (Guidotti et al. 2015) . The relationship between these protrusions and TEHLI is not known. However, these provide a possible mechanism for formation of an immunological synapse between CD8+ T cells and malariainfected hepatocytes (Dustin and Groves 2012) , enabling elimination of the infected hepatocyte.
However, at least in mice, IFN-γ may be the principal mediator of protective immunity to liver stages (McCall and Sauerwein 2010) , although studies in mice, and some human studies, also suggest the role of other soluble mediators as well direct cell-tocell cytotoxicity (Doolan and Hoffman 2000) . In this respect, inhibition of iNOS significantly reduced spleen cell elimination of infected hepatocytes, consistent with the role of IFN-γ induction of iNOS as a principal pathway of spleen cell activity Scheller, Green and Azad 1997; Franke et al. 2000) .
Support for direct cell-to-cell contact was also shown by the inhibitory activity of ant-ICAM-1 antibodies consistent with other studies (Warren et al. 2006) , most likely by disrupting the engagement of LFA-1 with ICAM-1 (Marlin and Springer 1987) . ICAM-1 has been detected on the membranes of hepatocytes and can mediate lymphocyte binding (Bertolino et al. 2005 , Reglero-Real et al. 2014 . Since expression of ICAM-1 is associated with NFκB, inhibition of NFκB activity also blocked spleen cell elimination of P. yoelii-infected hepatocytes, supporting the requirement for direct spleen cell contact with infected hepatocytes.
Our results shed further light on the mechanisms that the immune system can utilize to inhibit parasite develop in hepatocytes and provide some new information about the key players in the immune response to liver stage parasites.
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